# Rury R. Holman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rury-r-holman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 62,632 |
| Field | Diabetes Treatment and Management |
| h-index | 99 |
| i10-index | 304 |
| Last Known Institution | University of Oxford |
| OpenAlex ID | https://openalex.org/A5049740900 |
| ORCID iD | 0000-0002-1256-874X |
| Works | 576 |

## Researcher papers

Showing 12 of 17.

- [10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes](https://scholariq.org/papers/10-year-follow-up-of-intensive-glucose-control-in-type-2-diabetes/)
- [Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy](https://scholariq.org/papers/medical-management-of-hyperglycemia-in-type-2-diabetes-a-consensus-algorithm-for/)
- [Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy](https://scholariq.org/papers/glycemic-durability-of-rosiglitazone-metformin-or-glyburide-monotherapy/)
- [Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/effect-of-sitagliptin-on-cardiovascular-outcomes-in-type-2-diabetes/)
- [Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/effects-of-once-weekly-exenatide-on-cardiovascular-outcomes-in-type-2-diabetes/)
- [Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)](https://scholariq.org/papers/risk-factors-for-coronary-artery-disease-in-non-insulin-dependent-diabetes/)
- [Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)](https://scholariq.org/papers/development-and-progression-of-nephropathy-in-type-2-diabetes-the-united-kingdom/)
- [Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/albiglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes-and/)
- [Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-a-consensus-algorithm-for-the/)
- [Intensive glucose control and macrovascular outcomes in type 2 diabetes](https://scholariq.org/papers/intensive-glucose-control-and-macrovascular-outcomes-in-type-2-diabetes/)
- [Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis](https://scholariq.org/papers/pharmacological-blood-pressure-lowering-for-primary-and-secondary-prevention-of/)
- [Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis](https://scholariq.org/papers/cardiovascular-outcomes-with-glucagon-like-peptide-1-receptor-agonists-in/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

## Researcher university

- [University of Oxford](https://scholariq.org/institutions/university-of-oxford/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.